Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B

Infection and Immunity

Volumn 71, Issue 9, 2003, Pages 5225-5230

  Shimomura, Hirofumi ^a   Matsuura, Motohiro ^a   Saito, Shinji ^a   Hirai, Yoshikazu ^a   Isshiki, Yasunori ^b,c   Kawahara, Kazuyoshi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c JOSAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BURKHOLDERIA CEPACIA; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SALMONELLA ENTERICA;

ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; POLYMYXIN B; SEPHAROSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041823375     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.9.5225-5230.2003     Document Type: Article

References (35)

1. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharide and innate immunity. J. Endotoxin Res. 7:167-202.
2. Asanuma, Y., T. Furuya, J. Tanaka, T. Sato, S. Shibata, and K. Koyama. 1999. The application of immobilized polymyxin B fiber in the treatment of septic shock associated with severe acute pancreatitis: report of two cases. Surgery Today 29:1177-1182.
3. Ayala, J. M., T. T. Yamin, L. A. Egger, J. Chin, M. J. Kostura, and D. K. Miller. 1994. IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153:2592-2599.
4. Boll, M., J. Radziejewska-Lebrecht, C. Warth, D. Krajewska-Pietrasik, and H. Mayer. 1994. 4-Amino-4-deoxy-L-arabinose in LPS of enterobacterial R-mutants and its possible role for their polymyxin reactivity. Immunol. Med. Microbiol. 8:329-342.
5. Correia, J. D. S., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. J. Biol. Chem. 276:21129-21135.
6. Cox, A. D., and S. G. Wilkinson. 1991. Ionizing groups in lipopolysaccharides of Pseudomonas cepacia in relation to antibiotic resistance. Mol. Microbiol. 5:641-646.
7. Coyne, C. P., and B. W. Fenwick. 1993. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-α synthesis by polymyxin B sulfate. Am. Vet. Res. 54:305-314.
8. Galanos, C., O. Lüderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novopyrexal). Zentbl. Bakteriol. Hyg. Abt. 1 Orig. A 243:226-244.
9. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence of transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
10. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
11. Gronow, S., C. Noah, A. Blumentha, B. Lindner, and H. Brade. 2003. Construction of a deep-rough mutant of Burkholderia cepacia ATCC 25416 and characterization of its chemical and biological properties. J. Biol. Chem. 278:1647-1655.
12. Issiki, Y., K. Kawahara, and U. Zähringer. 1998. Isolation and characterisation of disodium (4-amino-4-deoxy-β -L-arabinopyranosyl)-(1→8)-(D-glycero-α -D-talo-octo-2-ulopyranosylonate)-(2→4) -(methyl-3-deoxy-D-manno-octo-2-ulopyranoside) onate from the lipopolysaccharide of Burkholderia cepacia. Carbohydr. Res. 313:21-27.
13. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
14. Lipuma, J. J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19:473-486.
15. Lipuma, J. J., S. E. Dasen, D. W. Neilson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:527-532.
16. Lonneman, G., S. Endres, J. W. V. D. Meer, K. M. Koch, and C. A. Dinarello, 1989. Differences in the synthesis and kinetics of release of interleukin 1. Eur. J. Immunol. 19:1531-1536.
17. Matsuda, T., T. Hirano, and T. Kishimoto. 1987. Establishment of an interleukin-6 (IL-6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immunol. 18:951-956.
18. Moore, R. A., and R. E. T. Hancock. 1986. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30:923-926.
19. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
20. Mosman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J. Immunol. Methods 65:55-63.
21. Nakamura, T., I. Ebihara, H. Shoji, C. Ushiyama, S. Suzuki, and H. Koide. 1999. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm. Res. 48:171-175.
22. Nummila, K., I. Kilpelainen, U. Zähringer, M. Vaara, and I. M. Helander. 1995. Lipopolysaccharide of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol. Microbiol. 16:271-278.
23. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
24. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 108:830-834.
25. Radziejewska-Lebrecht, J., U. R. Bhat, M. Brade, and H. Mayer. 1988. Structural studies on the core and lipid A region of a 4-amino-arabinose-lacking Rc-type mutant of Proteus mirabilis. Eur. J. Biochem. 183:573-581.
26. Rifkind, D. 1967. Prevention by polymyxin B of endotoxin lethality in mice. J. Bacteriol. 93:1463-1464.
27. Ruff, M. R., and G. E. Gilfford. 1980. Purification and physiological characterization of rabbit tumor necrosis factor. J. Immunol. 125:1671-1677.
28. Schumann, R. R., C. Belka, D. Reuter, N. Lamping, C. J. Kirschning, J. R. Weber, and D. Pfeil. 1998. Lipopolysaccharide activates caspase-I (interleukin-1-converting enzyme) in cultured moncytic and endothelial cells. Blood 91:577-584.
29. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782.
30. Shimomura, H., M. Matsuura, S. Saito, Y. Hirai, Y. Issiki, and K. Kawahara. 2001. Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1β-inducing ability. Infect. Immun. 69:3663-3669.
31. Stokes, D. C., J. L. Shenep, M. Fishmen, W. K. Hildner, G. K. Bysani, and K. Rufus. 1989. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-α from alveolar macrophages. J. Infect. Dis. 160:52-57.
32. Vaara, M. 1992. Agents that increase the permeability of the outer membrane. Rev. Microbiol. 56:395-411.
33. Vaara, M., T. Vaara, M. Jensen, I. Helander, M. Numinen, E. T. Rietschel, and P. H. Mäkelä. 1981. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutant of Salmonella typhimurium. J. Bacteriol. 139:664-667.
34. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
35. Yabuuchi, E., Y. Kosako, H. Oyaizu, I. Yano, H. Hotta, Y. Hashimoto, T. Ezaki, and M. Arakawa. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species of Burkholderia cepacia (Palleroni and Holmes) comb. nov. Microbiol. Immunol. 36:1251-1275.